Figure 3From: A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer pain Least-squares mean differences and 95% confidence intervals between the OROS ® hydromorphone and controlled-release (CR) morphine groups at end of the sustained-release (SR) phase. Back to article page